Better Therapeutics, Inc. (BTTX)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Aug 1, 2025, 1:40 PM EDT
Chimerix Market Cap
Better Therapeutics has a market cap or net worth of $5.45 thousand as of August 1, 2025. Its market cap has decreased by -99.95% in one year.
Market Cap
5.45K
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since March 17, 2021, Better Therapeutics's market cap has decreased from 66.05M to 5.45K, a decrease of -99.99%. That is a compound annual growth rate of -88.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2025 | 5.45K | - |
| Dec 31, 2024 | 5.45K | -99.94% |
| Dec 29, 2023 | 9.24M | -64.77% |
| Dec 30, 2022 | 26.24M | -76.09% |
| Dec 31, 2021 | 109.74M | 66.14% |
| Mar 17, 2021 | 66.05M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.80B |
| Veradigm | 794.80M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 546.09M |
| Glass House Brands | 396.28M |
| Nika Pharmaceuticals | 366.89M |
| Northwest Biotherapeutics | 361.28M |
| CytoDyn | 357.98M |